How Many Observations are Hiding in Your Quality System?
Our experts take a close look at why you should maintain regulatory…
Read Blog Post
6 Tips to Prepare Your Medical Cannabis Facility for Inspection
What steps should you take to ensure your medical cannabis facility is…
Read Blog Post
Odyssey Investment Partners To Acquire ProPharma Group
Odyssey Investment Partners (“Odyssey”) announced today that it has entered into an…
Read Blog Post
Linden Agrees to Sell ProPharma Group to Odyssey Investment Partners
Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on…
Read Blog Post
3 Basic Data Integrity Principles to Protect Value and Drive...
While an abundance of data and complex processes may not be easy…
Read Blog Post
7 Tips to Help You Prepare for Compliance in a...
Companies operating under relaxed enforcement discretion due to COVID-19 should prepare now,…
Read Blog Post
Meet the Expert: Simona Mills, PMP
ProPharma Group has launched a “Meet the Expert” series introducing you to…
Read Blog Post
Biosimilars: How the Approval Process Differs from a Standard ANDA
When seeking regulatory review and approval of a biosimilar, it is critical…
Read Blog PostYour Business has Complex Challenges. ProPharma Group has Exceptional Solutions.
We partner with pharmaceutical, biotechnology, and medical device clients to tackle complex challenges. Contact us to learn how our experienced team can help ensure regulatory and development success throughout the product lifecycle.
Interested in gaining an industry edge? Let us help you stay up to date.
Sign up to receive updates and industry insights